Fernando Moreno Selected Research

Fernando Moreno Research Topics

Disease

24	Breast Neoplasms (Breast Cancer) 05/2024 - 12/2004
14	Neoplasms (Cancer) 05/2023 - 01/2014
8	Triple Negative Breast Neoplasms 03/2024 - 01/2016
4	Pathologic Complete Response 03/2024 - 02/2017
3	Neoplasm Metastasis (Metastasis) 05/2024 - 12/2015
3	Cardiotoxicity 01/2023 - 07/2015
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 11/2011
2	Heart Failure 01/2023 - 12/2004
2	Hyperthermia 01/2022 - 01/2022
1	Shock 04/2024
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2023
1	Left Ventricular Dysfunction 01/2023
1	Constipation 01/2023
1	Asthma (Bronchial Asthma) 12/2021
1	Obstructive Sleep Apnea 12/2020
1	COVID-19 12/2020
1	Residual Neoplasm 11/2018
1	Vomiting 05/2016
1	Nausea 05/2016
1	Disease Progression 10/2005
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2005
1	Vulvar Neoplasms (Vulvar Cancer) 05/2005
1	Hemangiosarcoma (Angiosarcoma) 05/2005
1	Sarcoma (Soft Tissue Sarcoma) 05/2005
1	Lymphoma (Lymphomas) 05/2005
1	Astigmatism 05/2002
1	Myopia 05/2002

Drug/Important Bio-Agent (IBA)

8	AnthracyclinesIBA 03/2024 - 12/2004
7	Docetaxel (Taxotere)FDA Link 01/2021 - 05/2016
6	Trastuzumab (Herceptin)FDA Link 01/2023 - 10/2005
5	Hormones (Hormone)IBA 07/2023 - 12/2020
5	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2015
3	Estrogen ReceptorsIBA 07/2023 - 01/2019
3	PlatinumIBA 12/2018 - 01/2016
3	Sunitinib (Sutent)FDA Link 01/2017 - 11/2011
2	Aromatase InhibitorsIBA 05/2024 - 07/2023
2	Formaldehyde (Formol)FDA Link 01/2023 - 12/2015
2	palbociclibIBA 01/2023 - 12/2020
2	ParaffinIBA 01/2023 - 12/2015
2	pembrolizumabIBA 10/2021 - 08/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 11/2018
2	Taxoids (Taxanes)IBA 01/2021 - 11/2018
2	ErbB Receptors (EGF Receptor)IBA 12/2020 - 10/2014
2	Circulating Tumor DNAIBA 12/2019 - 01/2017
2	taxaneIBA 12/2018 - 02/2017
1	Everolimus FDA Link 05/2024
1	LigandsIBA 07/2023
1	GoldIBA 05/2023
1	pertuzumabIBA 01/2023
1	Fulvestrant (Faslodex)FDA Link 01/2023
1	Fibronectins (Fibronectin)IBA 08/2022
1	Extracellular Matrix ProteinsIBA 08/2022
1	Nitrogen DioxideIBA 12/2021
1	Gemcitabine FDA Link 10/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 11/2018
1	Genetic Markers (Genetic Marker)IBA 11/2018
1	Cytochrome P450 Family 1IBA 11/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	Aprepitant (Emend)FDA Link 05/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2016
1	AntiemeticsIBA 05/2016
1	Serotonin (5 Hydroxytryptamine)IBA 05/2016
1	human ERBB2 proteinIBA 10/2014
1	Lapatinib (GW572016)FDA Link 10/2014
1	MicroRNAs (MicroRNA)IBA 01/2014
1	Tyrosine Kinase InhibitorsIBA 11/2011
1	Cytochrome P-450 CYP3AIBA 11/2011
1	thiamine triphosphorate (TTP)IBA 10/2005
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2004
1	liposomal doxorubicin (Doxil)FDA Link 12/2004

Therapy/Procedure

12	Therapeutics 05/2024 - 12/2004
9	Drug Therapy (Chemotherapy) 05/2024 - 07/2015
5	Neoadjuvant Therapy 03/2024 - 01/2016
1	Local Anesthesia 04/2024
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Continuous Positive Airway Pressure 12/2020
1	Immunotherapy 08/2020
1	Salvage Therapy 05/2016
1	Drug Tapering 11/2011
1	Radiotherapy 05/2005
1	Laser In Situ Keratomileusis (LASIK) 05/2002
1	Excimer Lasers 05/2002